Cited by 50Uterine Myomas and TreatmentsReproductive Health and ContraceptionGynecological conditions and treatments

Hormone therapy for intramural myoma-related infertility from ulipristal acetate to GnRH antagonist: a review

Open access
Donnez, Jacques, Dolmans, Marie-Madeleine·2020·Reproductive BioMedicine Online

Abstract

Uterine fibroids may cause infertility, depending on their size and location according to the International Federation of Gynecology and Obstetrics classification. In this review, infertility relating to intramural myomas is evaluated. The mechanisms linking uterine fibroids and infertility are numerous: uterine cavity distortion (fibroids types 0, 1, 2, 2-5); impaired endometrial and myometrial blood supply; increased uterine contractility; hormonal, paracrine and molecular changes; impaired endometrial receptivity in gene expression (decrease in homeobox 10 [HOXA-10] expression); and thicker capsule. The negative effect of intramural myoma is related to myoma size and proximity of the uterine cavity. Therefore, a medical approach could be proposed to reduce the size of the myoma and push it back deep into the myometrium. The relevant medical treatments, including selective progesterone receptor modulator and gonadotrophin releasing hormone antagonist are reviewed. Even if the mystery surrounding intramural myomas remains, the development of new algorithms for intramural myoma-related infertility, and evaluation of the place of medical treatment as a primary approach are urgently needed. An algorithm, taking into account the mechanisms linking uterine fibroids and infertility, is proposed.

Integrity signals

Registry

Crossref · 10.1016/j.rbmo.2020.05.017

Cites

109 of 109 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • SPRMs are not an option for endometriosis because they induce progesterone modulator-associated endometrial changes (PAECs) in ectopic foci and their efficacy is limited.

    “among new drugs, selective progesterone receptor modulators (SPRMs) are not an option as they induce progesterone modulator-associated endometrial changes (PAECs) in ectopic foci and their efficacy is limited [89,90,91].”

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Donnez, J., & Dolmans, M.-M.
Affiliations
  • UCLouvain (BE)
  • Cliniques Universitaires Saint-Luc (BE)
Corresponding author
Donnez, Jacques
Venue
Reproductive BioMedicine Online
Publisher
Elsevier BV
Published
2020-09
Volume
41
Issue
3
Pages
431-442
ISSN
1472-6483 (ISSN-L)
OpenAlex
W3034352648
Cited by
50
References
109
Citations by year
2026: 3 · 2025: 7 · 2024: 5 · 2023: 15 · 2022: 6 · 2021: 10 · 2020: 3
FWCI
1.00
Type
journal article
Language
en
Open access
Locations
  • Reproductive BioMedicine Online (publishedVersion)
  • PubMed (publishedVersion)
  • Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion, other-oa)
Funders
Fondation contre le Cancer
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Uterine Myomas and Treatments
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
Keywords
intramural uterine fibroids, ulipristal acetate, GnRH antagonist, selective progesterone receptor modulators, endometrial receptivity, HOXA10, uterine contractility, treatment algorithm
MeSH terms
Female, Hormone Antagonists, Humans, Infertility, Female, Leiomyoma, Norpregnadienes, Uterine Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review